WALTHAM, Mass.--(BUSINESS WIRE)--Nursing students today face a range of challenges, from applying theoretical knowledge to their assignments to learning complex nursing terminology and retaining information from extensive reading. To help students enhance their understanding of concepts, knowledge, and curriculum, Wolters Kluwer Health announces the introduction of Lippincott® CoursePoint+ with Expert AI. This new learning solution has been designed with extensive input and testing by nurse edu. ...

I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view of my portfolio, given my particular background.If you have any questions, feel free to reach out to me via a direct message on Seeking Alpha or leave a comment on one of my articles.Analyst’s Disclosure:I/we have a beneficial long position in the shares of GOOG, NVDA either through stock ownership, options, or other derivatives. I wrote this article ...

Let's begin though with market reaction to the delayed jobs data, Jim. Once again, it's uh basically education and health services that are doing the the lion share of the work. >> Yeah, we don't want that.That's the old days. I wish there had been more manufacturing. I honestly think allowed the interesting piece today about Michael in Trader.Yes. >> Corwe in which you were quoted or at least referenced. >> It was quoted I think during the interview we conducted.Yes, Carl. >> So, it's nice to know that we ...

With a market cap of $22.5 billion, Ralph Lauren Corporation (RL) is a global lifestyle brand that designs, markets, and distributes premium apparel, accessories, home products, and fragrances worldwide. Its diverse portfolio includes well-known brands such as Polo Ralph Lauren, Ralph Lauren Collection, Purple Label, Double RL, Lauren Ralph Lauren, and Chaps, along with a wide range of men’s, women’s, and children’s products. Companies valued over $10 billion are generally described as “large-cap” stocks ...

The U.S. stock market has had an interesting year in 2025. The focus point has been between surging AI investments, President Trump’s quickly changing tariff policies, higher-for-longer interest rates, geopolitical risks and defense stocks, and increasing economic uncertainty in aI am an avid investor with a major focus on small cap companies with experience in investing in US, Canadian, and European markets. My investment philosophy to generating great returns on the stock market revolves around identifyin ...

GURUGRAM, India--(BUSINESS WIRE)--ReNew Energy Global Plc ("ReNew†), a leading decarbonisation solutions company, today announced that it has signed a long-term agreement with Google to enable the development of a new 150 megawatt (MW) solar project in Rajasthan. Under this partnership, Google will procure the project's energy attributes from ReNew. This long-term procurement is essential for the bankability of the project, and will also help Google make progress towards addressing its value chain emissio ...

The pneumococcal vaccine market has been dominated for years by large companies using conventional conjugate chemistry methods that are effective; however, there exists a biological ceiling known as "carrier suppression" which limits how far traditional conjugate chemistries canI have a strong inclination towards high-growth companies, often treading in sectors poised for exponential expansion. My expertise lies in understanding and investing in disruptive technologies and forward-thinking enterprises. My a ...

tete_escape / Shutterstock.com Key Points The Schwab US Dividend Equity ETF (SCHD) holds 103 blue-chip stocks and offers a 3.81% distribution yield with a 0.06% expense ratio. The VistaShares Target 15 Berkshire Select Income ETF (OMAH) mirrors Berkshire Hathaway’s top 20 holdings and delivers a 15% distribution yield through covered call options. OMAH pays monthly distributions versus SCHD’s quarterly schedule but charges a 0.95% expense ratio. If you’re thinking about retiring or know someone wh ...

D. Boral Capital analyst Jason Kolbert raised the firm’s price target on Quince Therapeutics (QNCX) to $5 from $4 and keeps a Buy rating on the shares after the company said the last patient has completed their last visit in the pivotal Phase 3 NEAT clinical trial evaluating encapsulated dexamethasone sodium phosphate in patients with Ataxia-Telangiectasia. The firm cites the rolling of its valuation metrics out a year for the target bump. Claim 50% Off TipRanks Premium and Invest with Confidence Unloc ...

Key Takeaways Walmart U.S. comp sales increased 4.5% in Q3, supported by higher transactions and unit volumes. Walmart saw traffic growth in stores and online, showing strength in its omnichannel model. Faster fulfillment and value pricing helped Walmart attract shoppers across income groups. Walmart Inc.’s (WMT) U.S. segment delivered a solid performance in the third quarter of fiscal 2026, with comp sales rising 4.5%. This growth was supported by increases in both transactions and unit volumes, signaling ...